Literature DB >> 21945657

Lung cancer histologies associated with emphysema on computed tomography.

Benjamin M Smith1, Kevin Schwartzman, Bojan Kovacina, Jana Taylor, Goulnar Kasymjanova, Guilherme Brandao, Jason S Agulnik.   

Abstract

BACKGROUND: Multiple studies have demonstrated an increased risk of lung cancer in the presence of emphysema detected visually on computed tomography (CT) independent of smoking history and airflow obstruction. The relationship between emphysema and specific histologic subtypes of lung cancer remains uncertain.
OBJECTIVE: To determine the extent to which emphysema on chest CT is associated with lung cancer histology.
METHODS: Cross-sectional analysis of consecutive lung cancer patients referred to the Jewish General Hospital was performed (2001-2009). All those with demographic data, smoking history (pack-years), documented histology and chest CT were included. Emphysema was graded on CT by three readers, using a standardized rubric. Odds of each lung cancer subtype were compared between patients with and without emphysema, and adjusted for age, sex, physician diagnosed COPD and smoking history by multiple logistic regression.
RESULTS: Complete data were available for 498 lung cancer patients (mean age 68 years; 44% female; 16% never smokers; 53% without emphysema on CT). The most common histologies were adenocarcinoma (242 [49%]), squamous (71 [14%]), undifferentiated (48 [10%]) and small cell carcinoma (42 [8%]). The presence of emphysema was associated with increased odds of squamous (OR 3.1; 95% CI 1.8-5.3) and small cell (OR 2.1; 95% CI 1.1-4.1) carcinoma. After adjustment for age, sex, COPD and smoking history, emphysema was associated with squamous (adjusted OR 2.6; 95% CI 1.4-4.8) but not small cell (adjusted OR 1.5; 95% CI 0.76-3.1) carcinoma. Sensitivity analysis was performed by sequential censoring of each histologic subtype yielding similar results. Adenocarcinoma was less common in the presence of emphysema relative to squamous and small cell carcinoma (adjusted OR 0.62; 95% CI 0.41-0.92). When these latter histologies were censored, no significant association between adenocarcinoma and emphysema was observed (adjusted OR 1.0; 95% CI 0.49-2.1).
CONCLUSIONS: Relative to other histologic subtypes, the odds of squamous carcinoma were significantly increased among lung cancer patients with emphysema after adjustment for age, sex, COPD and smoking history. Other common subtypes were not independently associated with emphysema. Copyright Â
© 2011 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Mesh:

Year:  2011        PMID: 21945657     DOI: 10.1016/j.lungcan.2011.09.003

Source DB:  PubMed          Journal:  Lung Cancer        ISSN: 0169-5002            Impact factor:   5.705


  20 in total

1.  Lung cancer and chronic obstructive pulmonary disease: understanding the complexity of carcinogenesis.

Authors:  Cecilia Mouronte-Roibás; Alberto Ruano-Raviña; Alberto Fernández-Villar
Journal:  Transl Lung Cancer Res       Date:  2018-09

2.  Associations Between Morphological Phenotypes of COPD and Clinical Characteristics in Surgically Resected Patients with COPD and Concomitant Lung Cancer.

Authors:  Yusuke Suzuki; Yoshiaki Kitaguchi; Fumika Ueno; Yunden Droma; Norihiko Goto; Takumi Kinjo; Yosuke Wada; Masanori Yasuo; Masayuki Hanaoka
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2022-06-21

3.  Does the presence of emphysema increase the risk of radiation pneumonitis in lung cancer patients?

Authors:  G Kasymjanova; R T Jagoe; C Pepe; L Sakr; V Cohen; D Small; T M Muanza; J S Agulnik
Journal:  Curr Oncol       Date:  2018-12-01       Impact factor: 3.677

4.  Prognostic significance of CT-emphysema score in patients with advanced squamous cell lung cancer.

Authors:  Young Saing Kim; Eun Young Kim; Hee Kyung Ahn; Eun Kyung Cho; Yu Mi Jeong; Jeong Ho Kim
Journal:  J Thorac Dis       Date:  2016-08       Impact factor: 2.895

5.  A simple prediction model using size measures for discrimination of invasive adenocarcinomas among incidental pulmonary subsolid nodules considered for resection.

Authors:  Hyungjin Kim; Jin Mo Goo; Chang Min Park
Journal:  Eur Radiol       Date:  2018-09-25       Impact factor: 5.315

Review 6.  Biomarkers in Exhaled Breath Condensate and Serum of Chronic Obstructive Pulmonary Disease and Non-Small-Cell Lung Cancer.

Authors:  Mann Ying Lim; Paul S Thomas
Journal:  Int J Chronic Dis       Date:  2013-08-01

Review 7.  Promising targets and current clinical trials in metastatic squamous cell lung cancer.

Authors:  Mark D Vincent
Journal:  Front Oncol       Date:  2014-12-09       Impact factor: 6.244

8.  Severity of pulmonary emphysema and lung cancer: analysis using quantitative lobar emphysema scoring.

Authors:  Kyungsoo Bae; Kyung Nyeo Jeon; Seung Jun Lee; Ho Cheol Kim; Ji Young Ha; Sung Eun Park; Hye Jin Baek; Bo Hwa Choi; Soo Buem Cho; Jin Il Moon
Journal:  Medicine (Baltimore)       Date:  2016-11       Impact factor: 1.889

Review 9.  Lung cancer and chronic obstructive pulmonary disease: From a clinical perspective.

Authors:  Jie Dai; Ping Yang; Angela Cox; Gening Jiang
Journal:  Oncotarget       Date:  2017-03-14

10.  Prognostic significance of CT-determined emphysema in patients with small cell lung cancer.

Authors:  Hee Young Lee; Eun Young Kim; Young Saing Kim; Hee Kyung Ahn; Yoon Kyung Kim
Journal:  J Thorac Dis       Date:  2018-02       Impact factor: 2.895

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.